Search Results - "Ellis, Charles N"
-
1
OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study
Published in Journal of the American Academy of Dermatology (01-08-2016)“…Background Peripheral leukocytes in patients with atopic dermatitis (AD) have elevated phosphodiesterase-4 activity, which is associated with production of…”
Get full text
Journal Article -
2
Dermoscopy can be safely and reliably used in ophthalmology
Published in Heliyon (15-05-2024)“…To determine if dermoscopy, a technique widely utilized in dermatology for improved diagnosis of skin lesions, can be used comfortably for evaluating…”
Get full text
Journal Article -
3
-
4
Novel systemic drugs under investigation for the treatment of psoriasis
Published in Journal of the American Academy of Dermatology (01-07-2012)“…In the last few years, there has been progress in identifying some of the risk genes for psoriasis. This has resulted in a major impetus toward drug…”
Get full text
Journal Article -
5
Atopic dermatitis: epidemiology and pathogenesis update
Published in Seminars in cutaneous medicine and surgery (01-09-2012)“…The prevalence of atopic dermatitis (AD) has increased markedly in the United States over the past 5 decades, with current reports varying from 10% to 20%…”
Get more information
Journal Article -
6
Uses and complications of isotretinoin therapy
Published in Journal of the American Academy of Dermatology (01-11-2001)“…Isotretinoin (13-cis-retinoic acid) is a retinoid that has been used over the past 2 decades to treat a wide variety of dermatologic conditions, some with…”
Get full text
Journal Article Conference Proceeding -
7
A Simulation-Based Workshop to Improve Dermatologists’ Communication Skills: A Pilot for Continuing Medical Education
Published in Dermatology and therapy (01-03-2019)“…Introduction Communication skills influence the quality of health care and patient experience; both may affect provider reimbursement. There are few…”
Get full text
Journal Article -
8
Pimecrolimus in dermatology: atopic dermatitis and beyond
Published in International journal of clinical practice (Esher) (01-08-2005)“…Pimecrolimus is a calcineurin inhibitor developed for the topical therapy of inflammatory skin diseases, particularly atopic dermatitis (AD). Pimecrolimus…”
Get more information
Journal Article -
9
Current issues in atopic comorbidities and preventing the atopic march
Published in Seminars in cutaneous medicine and surgery (01-09-2012)“…The individual, family, and public health burden of atopic dermatitis (AD) is considerable. The prevalence of AD is high, the signs and symptoms of the disease…”
Get more information
Journal Article -
10
Projected burden of melanoma clinical surveillance in the United States
Published in Journal of the American Academy of Dermatology (01-07-2024)Get full text
Journal Article -
11
Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment
Published in Journal of the American Academy of Dermatology (01-10-2004)“…Reliable assessment of severity in psoriasis is essential to document treatment responses in clinical research. The reliability of current clinical outcome…”
Get full text
Journal Article -
12
A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis
Published in The Journal of dermatological treatment (02-01-2016)“…Background: Moderate to severe plaque psoriasis (with or without psoriatic arthritis) places significant burden on patients' lives. Objective: Explore and…”
Get full text
Journal Article -
13
Epicardial adipose tissue volume is greater in men with severe psoriasis, implying an increased cardiovascular disease risk: A cross-sectional study
Published in Journal of the American Academy of Dermatology (01-03-2022)“…Patients with psoriasis have elevated risk of coronary artery disease. Do patients with severe psoriasis have larger epicardial adipose tissue volumes (EAT-V)…”
Get full text
Journal Article -
14
Psoriasis—recent advances in understanding its pathogenesis and treatment
Published in Journal of the American Academy of Dermatology (01-07-2005)“…Although not completely understood, there is clearly a genetic component in the development of psoriasis. Twin studies show a 67% concordance for monozygotic…”
Get full text
Journal Article -
15
Treatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes
Published in The New England journal of medicine (26-07-2001)“…Psoriasis is a skin disorder that affects approximately 2 percent of the world's population. 1 , 2 Although persons with mild psoriasis can often control the…”
Get full text
Journal Article -
16
Clinical Goals and Barriers to Effective Psoriasis Care
Published in Dermatology and therapy (01-03-2019)“…Engaging global key opinion leaders, the International Psoriasis Council (IPC) held a day-long roundtable discussion with the primary purpose to discuss the…”
Get full text
Journal Article -
17
Understanding and managing atopic dermatitis in adult patients
Published in Seminars in cutaneous medicine and surgery (01-09-2012)“…Atopic dermatitis (AD) in adults is an important dermatologic disease. Even in patients in whom the clinical presentation is mild, the burden of disease can be…”
Get more information
Journal Article -
18
BP-1107 [{2-[4-(2,4-dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: a novel synthetic thiazolidinedione that inhibits epidermal hyperplasia in psoriatic skin-severe-combined immunodeficient mouse transplants after topical application
Published in The Journal of pharmacology and experimental therapeutics (01-12-2005)“…Recent studies have demonstrated that orally administered thiazolidinedione ligands of the peroxisome proliferator-activated receptor-gamma can ameliorate…”
Get more information
Journal Article -
19
A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis
Published in Journal of the American Academy of Dermatology (01-12-2002)“…Background: In previous phase II studies, alefacept significantly improved psoriasis and was well tolerated. The clinical response to alefacept was durable…”
Get full text
Journal Article -
20
Ustekinumab: A New Option in Psoriasis Therapy
Published in Drugs (New York, N.Y.) (18-06-2009)“…Psoriasis is a chronic inflammatory disease that affects a significant portion of the population. Aside from the well known cutaneous and joint involvements,…”
Get full text
Journal Article